Previous studies suggested that tau phosphorylation at the Ser-422 can prevent the action of caspase-3, which is very active in Alzheimer's disease and truncates tau at Asp-421 (Guillozet-Bongaarts et al., 2006). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.